Ultrasound and Attenuation Imaging

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 14, 2024

Primary Completion Date

April 11, 2024

Study Completion Date

April 11, 2024

Conditions

Non-Alcoholic Fatty Liver DiseaseNon Alcoholic Fatty LiverNon-alcoholic SteatohepatitisSteatosis of Liver

Interventions

DEVICE

Ultrasound Attenuation imaging measurement

Participant to undergo conventional ultrasound scanning with attenuation measurement as well.

Trial Locations (1)

Bronglais Hospital, Aberystwyth

All Listed Sponsors

lead

Hywel Dda Health Board

OTHER

NCT06552377 - Ultrasound and Attenuation Imaging | Biotech Hunter | Biotech Hunter